MedTrace Logo

Usefulness of Calprotectin for Colon Adenoma Screening

NCT01719198 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2012-11-14

No results posted yet for this study

Summary

The fecal calprotectin assay is used widely for inflammatory bowel disease diagnosis and the assessment of the disease activity. Some adenoma patients have elevated fecal calprotectin level, which could mean the role of fecal calprotectin as a screening marker for colon adenoma. We will investigate the usefulness of fecal calprotectin as colon adenoma marker for screening in this study.

Conditions

  • Colon Adenoma

Sponsors & Collaborators

  • Konkuk University Medical Center

    lead OTHER

Principal Investigators

  • Yeo-Min Yun, MD, PhD · Konkuk University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2013-03-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01719198 on ClinicalTrials.gov